Literature DB >> 16450016

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

J Malcolm O Arnold1, Peter Liu, Catherine Demers, Paul Dorian, Nadia Giannetti, Haissam Haddad, George A Heckman, Jonathan G Howlett, Andrew Ignaszewski, David E Johnstone, Philip Jong, Robert S McKelvie, Gordon W Moe, John D Parker, Vivek Rao, Heather J Ross, Errol J Sequeira, Anna M Svendsen, Koon Teo, Ross T Tsuyuki, Michel White.   

Abstract

Heart failure remains a common diagnosis, especially in older individuals. It continues to be associated with significant morbidity and mortality, but major advances in both diagnosis and management have occurred and will continue to improve symptoms and other outcomes in patients. The Canadian Cardiovascular Society published its first consensus conference recommendations on the diagnosis and management of heart failure in 1994, followed by two brief updates, and reconvened this consensus conference to provide a comprehensive review of current knowledge and management strategies. New clinical trial evidence and meta-analyses were critically reviewed by a multidisciplinary primary panel who developed both recommendations and practical tips, which were reviewed by a secondary panel. The resulting document is intended to provide practical advice for specialists, family physicians, nurses, pharmacists and others who are involved in the care of heart failure patients. Management of heart failure begins with an accurate diagnosis, and requires rational combination drug therapy, individualization of care for each patient (based on their symptoms, clinical presentation and disease severity), appropriate mechanical interventions including revascularization and devices, collaborative efforts among health care professionals, and education and cooperation of the patient and their immediate caregivers. The goal is to translate best evidence-based therapies into clinical practice with a measureable impact on the health of heart failure patients in Canada.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16450016      PMCID: PMC2538984          DOI: 10.1016/s0828-282x(06)70237-9

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  156 in total

1.  Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure.

Authors:  J Dupuis; G Lalonde; R Lebeau; D Bichet; J L Rouleau
Journal:  Am Heart J       Date:  1990-09       Impact factor: 4.749

2.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Clarifying confusion: the confusion assessment method. A new method for detection of delirium.

Authors:  S K Inouye; C H van Dyck; C A Alessi; S Balkin; A P Siegal; R I Horwitz
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

5.  Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure.

Authors:  K Komamura; R P Shannon; A Pasipoularides; T Ihara; A S Lader; T A Patrick; S P Bishop; S F Vatner
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

Authors: 
Journal:  Lancet       Date:  1993-10-02       Impact factor: 79.321

7.  A prospective study of delirium in hospitalized elderly.

Authors:  J Francis; D Martin; W N Kapoor
Journal:  JAMA       Date:  1990-02-23       Impact factor: 56.272

8.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Authors:  M Packer; J R Carver; R J Rodeheffer; R J Ivanhoe; R DiBianco; S M Zeldis; G H Hendrix; W J Bommer; U Elkayam; M L Kukin
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

10.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

View more
  102 in total

Review 1.  Prevention of heart failure in the elderly: when, where and how to begin?

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 2.  Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada.

Authors:  Christopher S Simpson; Jeffrey S Healey; Francois Philippon; Paul Dorian; L Brent Mitchell; John L Sapp; Blair J O'Neill; Marcella M Sholdice; Martin S Green; Larry D Sterns; Raymond Yee
Journal:  Can J Cardiol       Date:  2006-07       Impact factor: 5.223

3.  The underuse of digoxin in heart failure, and approaches to appropriate use.

Authors:  Ali Ahmed; James B Young; Mihai Gheorghiade
Journal:  CMAJ       Date:  2007-02-27       Impact factor: 8.262

4.  Necessary cautions when considering digoxin in heart failure.

Authors:  George A Heckman; Robert S McKelvie
Journal:  CMAJ       Date:  2007-02-27       Impact factor: 8.262

Review 5.  How applicable are clinical practice guidelines to elderly patients with comorbidities?

Authors:  Donatus R Mutasingwa; Hong Ge; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

6.  Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.

Authors:  Lizebeth Cox; Marita Kloseck; Richard Crilly; Carol McWilliam; Laura Diachun
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

7.  Appropriateness of serum digoxin levels.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Giorgio Brocco; Gian Cesare Guidi
Journal:  Eur J Clin Pharmacol       Date:  2007-09-16       Impact factor: 2.953

Review 8.  Office management of patients with diastolic heart failure.

Authors:  Katina Tzanetos; Derek Leong; Robert C Wu
Journal:  CMAJ       Date:  2009-03-03       Impact factor: 8.262

9.  Acute decompensated heart failure: an introduction.

Authors:  Eldon R Smith
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

10.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.